Question 1

What is the veterinary autoimmune disease therapeutics market worth?

Accepted Answer

The market for veterinary auto-immune therapeutics size was worth USD 3.1 billion in 2022 and is set to reach USD 5.2 billion in 2032 with a 5.3% CAGR from 2023 to 2032 driven by the increasing threat of transfer of zoonotic diseases among humans, rising incidence of auto-immune diseases in livestock animals and increasing awareness and diagnosis of autoimmune diseases.

Question 2

Why is the demand for corticosteroids growing?

Accepted Answer

The corticosteroids segment generated USD 1.1 billion in revenue in 2022 and is expected to grow significantly attributed to the increasing demand for corticosteroids as it helps in reducing the severity of symptoms and provide relief to affected animals.

Question 3

Which are the major companies in the veterinary auto-immune therapeutics industry?

Accepted Answer

Aratana Therapeutics Inc., Pfizer Inc., Vet-Stem Inc., Ambrx Inc., Taconic Biosciences Inc., JBS United, Virbac, Eli Lily and Company, and Jaguar Animal Health Inc. are some of the top enterprises engaged in the industry

Question 4

How big is the North America veterinary auto-immune therapeutics industry?

Accepted Answer

The North America veterinary auto-immune therapeutics market is expected to reach USD 2.2 billion in 2032 with a 5.5% CAGR from 2023-2032 attributed to the large population of companion animals, including dogs, cats, and horses across the region.

Veterinary Autoimmune Disease Therapeutics Market Share

Veterinary Auto-immune Therapeutics Market Share

Premium Report Details

Industries

Information

Link

Global Headquarters